No Prescription |
 |
 | ||
|
Flixonase 24HR Flovent |
|
| ||
No Prescription » Prescription Drugs 7 » Flixonase 24HR Flovent Flixonase 24-Hour contains a steroid called fluticasone propionate which treats inflamed tissue.Flixonase 24-Hour works by reducing swelling inside your nose. This makes breathing easier.Flixonase 24-Hour is used to treat seasonal allergies including hay fever. It is available from your pharmacist although you may have been prescribed Flixonase 24-Hour by your doctor.Flixonase 24-Hour is not addictive.In most cases Flixonase 24-Hour will control your seasonal allergy symptoms however in some instances you may need additional therapy especially to control eye symptoms.How much to useTwo sprays into each nostril once a day preferably in the morning unless your doctor or pharmacist tells you otherwise.Your doctor/pharmacist will advise you what to do if only one nostril is affected.The maximum amount of sprays per day must not be more than 2 sprays (200 mcg) into each nostril.You may not feel the maximum benefit from your medicine straight away but it is important that you continue to use it regularly. It may take a few days until you get maximum relief from your medicine.How long do I need to use the product for?Continue to use Flixonase 24-Hour regularly for as long as your doctor or pharmacist tells you to.If you forget to use itIf it is almost time for your next dose skip the dose you missed and use your next dose when you are meant to. Otherwise use the product as soon as you remember then go back to using the product as you would normally.Do not use a double dose to make up for the dose that you missed. Buy Flixonase 24HR Flovent and other Prescription Drugs 7 products online at Medstore. 5281
About Flixonase 24HR Flovent: Product Type: Prescription Drugs 7 Flixonase 24HR ( Flovent Generic Fluticasone propionate ) Flixonase 24HR (Flovent Generic Fluticasone propionate) Flovent Generic Fluticasone propionate 50mcg per actuation 120 Sprays Flovent Generic Fluticasone propionate Flixonase 24HR
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
